Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

Ungulate community dynamics and associated environmental variables at Buffalo Ford Lake and the lower Lamar Valley during the last <i>c</i>. 2300 years. by John A. F. Wendt (19976392)

Primers used for SACMV DNA-A and DNA-B virulence proteins and PacBio SMRT sequence of NLR and LRR-PK/PL genes. by Bulelani L. Sizani (21485746)

Subjects:

AVAcore placement. by Jacob P. Rastas (20642173)

Subjects:

S1 File - by Jacob P. Rastas (20642173)

Subjects:

Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

Subjects:

Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

Subjects:

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

(A) Thermocouple positions for the MIPS and MONO systems. (B) Preparation of bone cubes from fresh cow tibias further employed for ex vivo mechanical evaluation, osteotomy and bone... by Marsel Ganeyev (21453399)

Subjects:

Diagram of the mediating model of the relationship between increased inhibition in the increase of mindfulness level and the decrease of mobile phone addiction index. by Jizhao Li (5856650)

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. by Hakim Ben Abdallah (14578241)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

CVD and mortality outcomes hazard ratio (HR) by years since quit smoking among former smokers compared with current and never smokers. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

Subjects:

Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

Subjects:

Association between smoking status and incidence of cardiovascular and mortality outcomes among men. by Erfan Tasdighi (9144667)

Subjects: